Skip to content

Innoviva, Inc. INVA Total Operating Expenses

Total Operating Expenses at other companies

ArriVent BioPharma, Inc. logo
ArriVent BioPharma, Inc.AVBP
$46.11M-30.9%
Option Care Health, Inc. logo
Option Care Health, Inc.OPCH
$189.47M+3.0%
Protagonist Therapeutics logo
Protagonist TherapeuticsPTGX
$60.02M+26.0%
Immunovant, Inc. logo
Immunovant, Inc.IMVT
$159.55M+40.2%
Apogee Therapeutics, Inc. logo
Apogee Therapeutics, Inc.APGE
$82.77M+31.2%
Savara logo
SavaraSVRA

Other financials

Income statement

See full
Revenue$98.0M+10.6%
Gross profit$75.8M+3.4%
Operating income$38.2M-7.9%
Net income$186.6M+501%
EPS (diluted)$2.22+400%

Balance sheet

See full
Cash & equivalents$603.1M+89.0%
Total debt$269.4M-40.3%
Total equity$1.3B
Total assets$1.8B+46.4%

Cash flow

See full
Operating cash flow$35.3M-27.4%
CapEx$492.0K
Free cash flow$34.8M-28.4%

Valuation

See full
Market cap$1.74B+51.8%
Enterprise value$1.41B+9.7%
P/E3.5×
P/S4.2×+1.0×

Profitability

See full
Gross margin73.7%-9.9pp
Operating margin38.1%-11.2pp
Net margin119.9%+107pp
FCF margin54.1%+5.3pp

Returns & leverage

See full
Return on equity29.1%
Debt / equity0.2×
Current ratio21.1×+18.7×

Where this comes from

Reported directly by Innoviva, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingExpenses.

The official record: Innoviva, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Innoviva, Inc.'s total operating expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Innoviva, Inc.'s total operating expenses?
Innoviva, Inc. (INVA) reported total operating expenses of $37.68M in Q1 2026.
How has Innoviva, Inc.'s total operating expenses changed year-over-year?
Innoviva, Inc.'s total operating expenses increased by 18.2% year-over-year, from $31.89M to $37.68M.
What is the long-term trend for Innoviva, Inc.'s total operating expenses?
Over 3 years (2021 to 2025), Innoviva, Inc.'s total operating expenses has grown at a 10.6% compound annual growth rate (CAGR), from $106.35M to $143.92M.
What does total operating expenses mean?
The sum of all operating costs including COGS, SG&A, R&D, D&A, and other operating charges. Revenue minus total operating expenses equals operating income.